VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 168 filers reported holding VIKING THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,147,000 | – | 123,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $2,613,000 | 6.32% |
| Opaleye Management Inc. | 825,000 | $14,371,000 | 3.66% |
| Prosight Management, LP | 274,410 | $4,780,000 | 2.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 859,727 | $14,976,000 | 1.72% |
| KNOTT DAVID M | 236,600 | $4,122,000 | 1.34% |
| Sio Capital Management, LLC | 213,252 | $3,715,000 | 1.28% |
| NEXTHERA CAPITAL LP | 327,730 | $5,709,000 | 1.09% |
| EAM Global Investors LLC | 115,781 | $2,017,000 | 0.82% |
| Nicholas Investment Partners, LP | 580,028 | $10,104,000 | 0.81% |
| Park West Asset Management LLC | 1,269,107 | $22,108,000 | 0.80% |